Navigation Links
Novel molecules developed at UB can boost vaccine potency
Date:2/5/2008

ted.

The one problem researchers may encounter and on which they are working currently is to ensure that their vaccine booster doesnt travel to the brain via the olfactory nerve, or if the booster does traffic to the brain, that it doesnt have harmful properties. Connell said some of the mutant LT-IIa and LT-IIb adjuvants they have developed appear to exhibit no toxicity in cells, and thus have the potential to exert no harmful effects on neuronal cells. His molecules may be ready for human trials in a year, he said.


'/>"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
3. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
4. Novel Cooling Therapy May Have Aided Injured Football Player
5. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. GrantAdler Shipping Novel Implantable Vascular Access Port
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Novel strategy under study for aggressive leukemia
10. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
11. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...y could shape new treatments for secondary pneumon...swire/ -- Scientists at St. Jude Children,s Resear...atment for bacterial pneumonia following influenza...azithromycin, which kill bacteria by inhibiting th...tandard first-line treatment with the "beta-lactam...
(Date:1/8/2009)... hurtful comments, study suggests , , T...erestimate how strongly they would react to racist...e percent of study participants at York University...ment with a white person rather than a black one, ...bout the black person when he left the room. ,...
(Date:1/8/2009)...ldren,s Research Hospital have demonstrated a more...wing influenza. They found that the antibiotics cl... inhibiting their protein synthesis, are more effe...e "beta-lactam" antibiotic ampicillin, which cause...g is important because pneumonia, rather than the ...
(Date:1/8/2009)...PRNewswire-FirstCall/ -- Hanger Orthopedic Group, ...roughout the fourth quarter of 2008 it acquired Ma...ountain Orthotic-Prosthetics Center, Riessen,s Ort... Orthotics & Prosthetics, and Orthopedic Rehab...tient care centers to existing markets in Maine, L...
Breaking Medicine News(10 mins):Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 2Health News:Study Finds More Effective Treatment for Pneumonia Following Influenza 3Health News:Many Turn Blind Eye to Racism 2Health News:Study finds more effective treatment for pneumonia following influenza 2Health News:Study finds more effective treatment for pneumonia following influenza 3Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2
...f the major causes of death among South Africa's y...s said. // Head of Policy Co-ordination and Advis...nzhe said they had conducted research and found th...e in HIV-AIDS-related deaths among young South Afr...
...complex mouth movements like blowing bubbles and l...age quickly, researchers say. // Katie Alcock and...tain studied 120 toddlers and carried out a series...s that might predict a child's ability to develop ...
...t transplants are on the decline. This is because ...y//. Hence the doctors at the Papworth Hospital in...rt was kept beating for five hours after it was re...n to receive a beating heart transplant was Michae...
...y of Adrian Bird, a molecular geneticist at the Un...23rd June// that the abnormally high levels of a p...s models of Rett Syndrome is causing its mitochond...rk overtime. Dr. Bird stated that this is the firs...
Other Medicine News:Health News:Latest In the Heart Transplant Field 2Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 2Health News:Researchers Have Linked Rett Syndrome to Mitochondrial Gene 3
(Date:1/8/2009)...O, Jan. 8 If you are taking prescr...re not alone. Half of the people taking,prescript...ons are,varied -- they forget, are busy with othe.... Noncompliance has been called the Achilles heel ...verett Koop commented, "Drugs don,t,work in peopl...
(Date:1/8/2009)...reated at the initial dose in an ongoing Phase Ib ...ecline after three days , , Conference Call Tod...wire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (N...irst cohort of an ongoing Phase Ib clinical trial ...oside polymerase inhibitor. ANA598 was very well-...
(Date:1/7/2009)...enn., Jan. 7 Scientists...a high likelihood of relapse in children with acut...rchers caution that further research is needed to ...or IKAROS, lead to leukemia relapse, the finding...ostic tests to assess the risk of treatment failur...
(Date:1/7/2009)... Md., Jan. 7 ImQuest Life Sciences...ND application to the Food and Drug Administration...pyrimidinedione HIV inhibitor IQP-0410. ImQuest an...first quarter of 2009. IQP-0410 is a novel small m... nonnucleoside reverse transcriptase inhibitor (NN...
Breaking Medicine Technology:Good Medicine: Smarter Smartphones for People With Chronic Disease 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2Baxter Announces FDA Approval of GELFOAM 28R 29 Plus Hemostasis Kit 2253 1Baxter Announces FDA Approval of GELFOAM 28R 29 Plus Hemostasis Kit 2253 2Baxter Announces FDA Approval of GELFOAM 28R 29 Plus Hemostasis Kit 2253 3Baxter Announces FDA Approval of GELFOAM 28R 29 Plus Hemostasis Kit 2253 4Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 1Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 2Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 3Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 4Angiotech Submits 510 28K 29 To FDA For Its Innovative 5 FU CVC 2251 5WallSt net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies 2249 1WallSt net Announces Upcoming Interview With CEO of ReBuilder Medical Technologies 2249 2LeMaitre Vascular Appoints Russell D Hays to Its Board of Directors 2247 1LeMaitre Vascular Appoints Russell D Hays to Its Board of Directors 2247 2
...oved by FDA for long-term,maintenance treatment of...nebulized formoterol fumarate provides improved lu...nhanced patient quality of,life, and positive safe...ta presented at the,International Conference of th... Perforomist™ (formoterol fumarate),Inhalati...
...The U.S. Food and Drug Administration,(FDA) is awa...(rosiglitazone), a drug approved to treat type 2 d...ls have shown that there is a,potentially signific...-related deaths in patients taking Avandia. Howeve...term clinical trials of,Avandia, including an inte...
Other Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7FDA Issues Safety Alert on Avandia 2FDA Issues Safety Alert on Avandia 3
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Durable ergonomic chairs with concave seats and large backrests with lumbar support • Select options like seats, backrests, armrests, and casters and glides. • Choose the BE Series for top
Medicine Products: